Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism αvβ1 modulators(Integrin alpha-V/beta-1 modulators), αvβ8 inhibitors(Integrin αvβ8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 06 Nov 2022 |